Mode
Text Size
Log in / Sign up
N/A N=30 Randomized Triple-blind Treatment

Vibration Impact on Parkinson's Tremor

Parkinson Disease

Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Dec 2020
Primary outcome: Primary: Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS) — 32.67; 27.4; 33.67; 27.33 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
RMBand lower dose (Device); RMBand higher dose (Device)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
Virginia Commonwealth University
Primary completion
Nov 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS)
32.67; 27.4; 33.67; 27.33; 32.67; 28.6
PRIMARY
Clinical Rating for Tremor
15.47; 13.87; 15.87; 13.20; 14.53; 14.13
PRIMARY
Objective Measurement of Tremor Frequency (Hz)
4.77; 4.51; 4.79; 3.99; 3.36; 4.64
PRIMARY
Objective Measurement of Tremor Amplitude (mm).
0.71; 0.43; 0.76; 0.44; 0.70; 0.52

Summary

The primary purpose of this study is to test the safety, tolerability and efficacy of vibration (delivered by an experimental device called RMBand that is worn on the subject's arm) on parkinsonian tremor. The RMBand was developed by Resonate Forward, LLC (RF). This RMBand is designed to administer a vibration to the wearer to decrease or stop tremor in persons with Parkinson's disease (PD).

Eligibility Criteria

Inclusion Criteria

  • Parkinson's disease (PD) as diagnosed by a movement disorder specialist
  • Tremor caused by their Parkinson's disease
  • Ability to provide informed consent

Exclusion Criteria

  • Known diagnosis of Parkinson Plus Syndrome
  • Dementia
  • Other known non-PD cause of tremor
  • Other known non-PD cause of limb dysfunction
  • Presence of implantable cardiac device, severe neuropathy or sensory loss that would prevent perception of vibration stimulus
  • Non-English speaker
  • Prisoners
  • Pregnant women
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03799614). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search